Peter Quehenberger

10.4k total citations · 1 hit paper
204 papers, 7.8k citations indexed

About

Peter Quehenberger is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Peter Quehenberger has authored 204 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Hematology, 62 papers in Internal Medicine and 45 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Peter Quehenberger's work include Blood Coagulation and Thrombosis Mechanisms (69 papers), Venous Thromboembolism Diagnosis and Management (62 papers) and Platelet Disorders and Treatments (36 papers). Peter Quehenberger is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (69 papers), Venous Thromboembolism Diagnosis and Management (62 papers) and Platelet Disorders and Treatments (36 papers). Peter Quehenberger collaborates with scholars based in Austria, United States and Germany. Peter Quehenberger's co-authors include Ingrid Pabinger, Cihan Ay, Bernd Jilma, Christoph Zielinski, Daniela Dunkler, Paul A. Kyrle, Rainer Vormittag, Christine Mannhalter, Wolfgang Speiser and Ralph Simanek and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Oncology.

In The Last Decade

Peter Quehenberger

195 papers receiving 7.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prediction of venous thromboembolism in cancer patients

2010 570 citations Cihan Ay, Peter Quehenberger et al. Blood profile →

Peers

Countries citing papers authored by Peter Quehenberger

Since Specialization

Citations

This map shows the geographic impact of Peter Quehenberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Quehenberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Quehenberger more than expected).

Fields of papers citing papers by Peter Quehenberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Quehenberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Quehenberger. The network helps show where Peter Quehenberger may publish in the future.

Co-authorship network of co-authors of Peter Quehenberger

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Quehenberger. A scholar is included among the top collaborators of Peter Quehenberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Quehenberger. Peter Quehenberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Estimating the Factor VIII‐Equivalent Activity of Emicizumab Using Global Assays of Haemostasis 2025 ·Haemophilia ·(unknown), Cihan Ay, (unknown), Georg Heinze, Peter Quehenberger, Ingrid Pabinger, Oliver Königsbrügge	0
2	The Vienna CATScore for predicting cancer-associated venous thromboembolism: an external validation across multiple time points 2025 ·ESMO Open ·(unknown), Stephan Nopp, Florian Moik, Angelika M. Starzer, Peter Quehenberger, Matthias Preusser, Anna S. Berghoff, Cihan Ay, Ingrid Pabinger	2
3	Von Willebrand factor for outcome prediction within different clinical stages of advanced chronic liver disease 2024 ·Alimentary Pharmacology & Therapeutics ·(unknown), Bernhard Scheiner, Alberto Zanetto, Lorenz Balcar, Georg Semmler, Elena Campello, Michael Schwarz, Rafael Paternostro, Benedikt Simbrunner, Benedikt Hofer, Albert Friedrich Stättermayer, Matthias Pinter, Michael Trauner, Peter Quehenberger, Paolo Simioni, Thomas Reiberger, Mattias Mandorfer	3
4	Detection of enoxaparin and argatroban by use of the novel viscoelastic coagulometer ClotPro 2024 ·Scientific Reports ·Johannes Gratz, (unknown), (unknown), (unknown), (unknown), Marion Wiegele, Peter Quehenberger, Eva Schaden	0
5	Platelet adhesion assessed by PFA-100 is not linked to progression of ACLD 2023 ·JHEP Reports ·Lorenz Balcar, Benedikt Simbrunner, Rafael Paternostro, Mathias Jachs, Lukas Hartl, Georg Semmler, Benedikt Hofer, Albert Friedrich Stättermayer, Matthias Pinter, Ton Lisman, Michael Trauner, Peter Quehenberger, Thomas Reiberger, Bernhard Scheiner, Mattias Mandorfer	2
6	Vitamin D deficiency in adult patients with primary immune thrombocytopenia (ITP) from the Vienna ITP Biobank 2023 ·Hämostaseologie ·(unknown), Michael Fillitz, (unknown), Peter Quehenberger, (unknown), Cihan Ay, Ingrid Pabinger, Johanna Gebhart	0
7	Factor VIII/protein C ratio independently predicts liver-related events but does not indicate a hypercoagulable state in ACLD 2022 ·Journal of Hepatology ·Bernhard Scheiner, Lorenz Balcar, (unknown), (unknown), Rafael Paternostro, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David Bauer, Albert Friedrich Stättermayer, Georg Semmler, Matthias Pinter, Cihan Ay, Peter Quehenberger, Michael Trauner, Thomas Reiberger, Ton Lisman, Mattias Mandorfer	24
8	Antithrombin Activity and Association with Risk of Thrombosis and Mortality in Patients with Cancer 2022 ·International Journal of Molecular Sciences ·(unknown), Oliver Königsbrügge, Stephan Nopp, Florian Moik, Peter Quehenberger, Matthias Preusser, Ingrid Pabinger, Cihan Ay	2
9	The von Willebrand factor–binding aptamer rondaptivon pegol as a treatment for severe and nonsevere hemophilia A 2022 ·Blood ·Cihan Ay, (unknown), (unknown), Christian Schoergenhofer, Georg Gelbenegger, Christa Firbas, Peter Quehenberger, Petra Jilma‐Stohlawetz, James C. Gilbert, Shuhao Zhu, Martin Béliveau, Franz Koenig, Alfonso Iorio, Bernd Jilma, Ulla Derhaschnig, Ingrid Pabinger	18
10	The VWF binding aptamer rondoraptivon pegol increases platelet counts and VWF/FVIII in type 2B von Willebrand disease 2022 ·Blood Advances ·Cihan Ay, Ingrid Pabinger, (unknown), Georg Gelbenegger, Christian Schörgenhofer, Peter Quehenberger, Petra Jilma‐Stohlawetz, Raute Sunder‐Plaßmann, James C. Gilbert, Shuhao Zhu, Bernd Jilma, Ulla Derhaschnig	20
11	Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19 2021 ·Journal of Personalized Medicine ·Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, David Bauer, Georg Semmler, Daniela Gompelmann, Thomas Szekeres, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Bernhard Scheiner, Thomas Reiberger	8
12	Culprit site extracellular DNA and microvascular obstruction in ST-elevation myocardial infarction 2021 ·Cardiovascular Research ·Andreas Mangold, Anna S. Ondracek, Thomas M. Hofbauer, Thomas Scherz, (unknown), (unknown), Dietrich Beitzke, (unknown), (unknown), (unknown), Robert Winker, Peter Quehenberger, Denise Traxler, Andreas Spannbauer, Mariann Gyöngyösi, Christoph Testori, Iréne Lang	27
13	Safety of direct oral anticoagulants in patients with advanced liver disease 2021 ·Liver International ·Georg Semmler, Katharina Pomej, David Bauer, Lorenz Balcar, Benedikt Simbrunner, Teresa Binter, Lukas Hartl, (unknown), Matthias Pinter, Peter Quehenberger, Michael Trauner, Mattias Mandorfer, Ton Lisman, Thomas Reiberger, Bernhard Scheiner	32
14	Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity 2020 ·Clinical Chemistry ·Thomas Perkmann, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, Robab Breyer‐Kohansal, Otto C. Burghuber, Sylvia Hartl, Daniel Aletaha, Daniela Sieghart, Peter Quehenberger, Rodrig Marculescu, Patrick Mucher, Robert Straßl, Oswald Wagner, Christoph J. Binder, Helmuth Haslacher	80
15	Influence of blood group, von Willebrand factor levels, and age on factor VIII levels in non‐severe haemophilia A 2020 ·Journal of Thrombosis and Haemostasis ·(unknown), Oliver Königsbrügge, Ella Grilz, Stefanie Hofer, Lisa‐Marie Mauracher, Cornelia Gabler, (unknown), Clemens Feistritzer, Raute Sunder‐Plaßmann, Peter Quehenberger, Johanna Gebhart, Cihan Ay, Ingrid Pabinger	15
16	The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver disease 2020 ·Liver International ·Bernhard Scheiner, Patrick G. Northup, (unknown), Georg Semmler, Gerda Leitner, Peter Quehenberger, J. Thaler, Cihan Ay, Michael Trauner, Thomas Reiberger, Ton Lisman, Mattias Mandorfer	23
17	Validation of rotation thrombelastography in a model of systemic activation of fibrinolysis and coagulation in humans 2006 ·Journal of Thrombosis and Haemostasis ·Alexander Spiel, Florian Mayr, Christa Firbas, Peter Quehenberger, Bernd Jilma	141
18	Massive postoperative intramuscular bleeding in acquired von Willebrand's disease 2002 ·Annals of Hematology ·Michael Krebs, Bernhard M. Meyer, Peter Quehenberger, Peter L. Turecek, Michael Hejna, Wolfgang R. Sperr, Klaus Lechner, Ingrid Pabinger	5
19	The Factor V (Leiden) Test 1999 ·Thrombosis Research ·Peter Quehenberger, Sylvia Handler, Christine Mannhalter, Paul A. Kyrle, Wolfgang Speiser	18
20	Occurrence of complement-fixing antibodies against Chlamydia psittaci and Toxoplasma gondii in pigs in the individual counties of Austria. 1990 ·Wiener Tierarztliche Monatsschrift ·Peter Quehenberger, (unknown), (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact